Related Experiment Videos
Cardiovascular calcification in end-stage renal disease
Isidro B Salusky1, William G Goodman
1Department of Pediatrics, UCLA School of Medicine, A2-331, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. isalusky@mednet.ucla.edu
Insights
Patients with end-stage renal disease (ESRD) face high cardiovascular risks due to factors like mineral metabolism disturbances. Reducing calcium load is crucial for managing cardiac calcifications in these patients.
Area of Science:
- Nephrology
- Cardiology
- Mineral Metabolism
Background:
- Cardiovascular diseases (CVD) are prevalent in end-stage renal disease (ESRD) patients, leading to significantly higher morbidity and mortality compared to the general population.
- Multiple factors contribute to this increased risk, including traditional risk factors (hypertension, diabetes, dyslipidemia) and unique ESRD-related issues like mineral metabolism abnormalities.
Purpose of the Study:
- To review cardiovascular complications associated with calcifications in ESRD patients.
- To explore the role of mineral metabolism abnormalities in the pathogenesis of these calcifications.
- To discuss current imaging techniques for detecting cardiovascular calcifications.
Main Methods:
- Literature review focusing on cardiovascular complications in ESRD.
- Analysis of the impact of mineral metabolism (calcium, phosphorus) on cardiovascular calcification.
- Evaluation of diagnostic imaging modalities for cardiovascular calcifications.
Main Results:
- Abnormalities in calcium and phosphorus homeostasis are key contributors to cardiovascular calcifications in ESRD.
- Elevated calcium load directly promotes cardiac calcifications.
- Various imaging techniques aid in the detection of these calcifications.
Conclusions:
- Cardiovascular calcification is a significant issue in ESRD, driven by mineral metabolism derangements.
- Strategies to reduce exogenous calcium load are essential for mitigating cardiac calcifications in ESRD patients.
- Further research into alternative therapeutic approaches is warranted.
Abstract:
Cardiovascular diseases are common in patients with end-stage renal disease (ESRD) and cardiovascular morbidity and mortality among dialysis patients are substantially higher than in the general population. The reasons for this high incidence are multiple. They include traditional factors such as hypertension, diabetes, dyslipidaemia, sodium overload, and elevated homocysteine levels as well as disturbances of mineral metabolism, specifically abnormalities in phosphorus and calcium homeostasis. This review will describe the specific cardiovascular complications related to calcifications in ESRD, the implications of the abnormalities of mineral metabolism in its pathogenesis and the current imaging techniques available for the detection of cardiovascular calcifications. Excess of calcium load contributes to the development of cardiac calcifications; therefore, alternative strategies to diminish exogenous calcium load should be considered in patients with ESRD.